Drieskens et al., 2005 - Google Patents
FDG-PET for preoperative staging of bladder cancerDrieskens et al., 2005
- Document ID
- 13683454781455342679
- Author
- Drieskens O
- Oyen R
- Van Poppel H
- Vankan Y
- Flamen P
- Mortelmans L
- Publication year
- Publication venue
- European journal of nuclear medicine and molecular imaging
External Links
Snippet
Purpose The presence of lymph node involvement (N) and distant metastasis (M) in patients with invasive bladder carcinoma is a major determinant of survival and, therefore, a pivotal element in the therapeutic management. The aim of this prospective study was to evaluate …
- 206010005003 Bladder cancer 0 title abstract description 21
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/321—Management of medical image data, e.g. communication or archiving systems such as picture archiving and communication systems [PACS] or related medical protocols such as digital imaging and communications in medicine protocol [DICOM]; Editing of medical image data, e.g. adding diagnosis information
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computerised tomographs
- A61B6/032—Transmission computed tomography [CT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/50—Clinical applications
- A61B6/502—Clinical applications involving diagnosis of breast, i.e. mammography
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Drieskens et al. | FDG-PET for preoperative staging of bladder cancer | |
Kitajima et al. | Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer | |
Morris et al. | MRI of occult breast carcinoma in a high-risk population | |
Fuster et al. | Preoperative staging of large primary breast cancer with [18F] fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures | |
Ruers et al. | Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study | |
Raveenthiran et al. | The use of 68 Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma | |
Lai et al. | Restaging of recurrent cervical carcinoma with dual‐phase [18F] fluoro‐2‐deoxy‐D‐glucose positron emission tomography | |
Scattoni et al. | Detection of lymph-node metastases with integrated [11C] choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy | |
Meltzer et al. | Whole-body FDG positron emission tomographic imaging for staging esophageal cancer: comparison with computed tomography | |
RAMDAVE et al. | Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma | |
Mangili et al. | Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer | |
Mitchell et al. | Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study | |
Heriot et al. | Does positron emission tomography change management in primary rectal cancer? A prospective assessment | |
Schilling et al. | Histological verification of 11C‐choline‐positron emission/computed tomography‐positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer | |
Leibold et al. | Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy | |
Klaeser et al. | PET-CT-guided interventions in the management of FDG-positive lesions in patients suffering from solid malignancies: initial experiences | |
Krueger et al. | Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours | |
Kang et al. | Clinical significance of incidental finding of focal activity in the breast at 18F-FDG PET/CT | |
Ito et al. | Fine‐needle aspiration biopsy and endoscopic ultrasound for pretreatment pathological diagnosis of gastric gastrointestinal stromal tumors | |
Kitajima et al. | Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer | |
Zervos et al. | Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup | |
Morita et al. | The accuracy of 18 [F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography, ultrasonography, and enhanced computed tomography alone in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma | |
Gillies et al. | Additional benefit of 18 F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer | |
Domachevsky et al. | Quantitative characterisation of clinically significant intra-prostatic cancer by prostate-specific membrane antigen (PSMA) expression and cell density on PSMA-11 | |
Selvaggi et al. | FGD‐PET in the follow‐up of recurrent colorectal cancer |